
zzso staging of prostate cancer at initial diagnosis, as well as accurate staging and tumor zzso with zzso zzso remains generally inaccurate with current imaging zzso Newer zzso are being investigated to accurately identify patients with prostate cancer at different stages of zzso Identification of locally zzso disease or distant zzso at the time of zzso failure after local therapy will help guide treatment options and avoid potentially toxic salvage therapies in patients who will not zzso A review of prostate cancer imaging literature over the past 12 months was performed to identify emerging imaging zzso that may be beneficial in the management of prostate zzso zzso zzso zzso zzso including ultrasound contrast agents, color and power zzso and zzso have demonstrated incremental benefit when combined with standard zzso zzso to accurately target and diagnose prostate zzso zzso zzso with contrast enhancement and zzso imaging, shows promise in the initial staging of prostate cancer prior to local zzso The use of zzso zzso scan for prostate cancer remains to be zzso but may help delineate the site of recurrence with zzso failure after local zzso Several new imaging zzso show promise for the evaluation of the patient with prostate zzso zzso zzso techniques may prove to be more accurate in diagnosing prostate cancer over standard zzso zzso zzso evidence supports the use of zzso zzso and zzso to help treatment planning with either surgical or zzso zzso Although intriguing, the available data for zzso zzso in prostate cancer remains too shallow to advocate routine zzso 

